SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study

Background: In a previous pilot weight-loss study, an association was observed between baseline fasting plasma glucose (FPG) levels and the effectiveness of the Gelesis100 treatment. The aim of this subanalysis of the Gelesis Loss Of Weight (GLOW; NCT02307279) study is to further assess the associat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Greenway, Frank, Fujioka, Ken, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Apovian, Caroline, Hill, James, Kaplan, Lee, Navas-Carretero, Santiago, Martinez, J., Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Calderon, Henry, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2019
Assuntos:
Adipose Tissue, Appetite, and Obesity
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552254/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares